Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-27 12:43:20 - browse：6

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： FDA approves Moderna’s RSV vaccine, its second licensed product

WSS

STAT Virtual Event: Putting AI to the Test

Medical student insurance fails on mental health care coverage

Medical student insurance fails on mental health care coverage

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Drug for rare kidney disease narrowly misses mark in clinical trial

Readout LOUD podcast: possible new ALS drug, artificial wombs

entertainment

Wikipedia

Wikipedia

Alkermes shareholders re

FDA panel to weigh approval of NurOwn, controversial ALS drug

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

What does generative AI mean for health care? We asked experts

CMS got Medicare Advantage quality rating wrong, judge rules

What does generative AI mean for health care? We asked experts

Microbiome research is starting to find links to chronic diseases

Continuity nursing helped my family in our darkest PICU moments

Sutter Health’s antitrust win overturned by appeals court

hotspot

CommonSpirit Health keeps growing, even as it loses money

ASCO Daily Recap: CAR

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

CDC advisers recommend seasonal use of Pfizer RSV shot

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

What Congress can do to address the rural doctor shortage

entertainment

entertainment

knowledge

hotspot